The Manufacturers Life Insurance Company Sells 1,919 Shares of American Healthcare REIT, Inc. (NYSE:AHR)

The Manufacturers Life Insurance Company trimmed its position in American Healthcare REIT, Inc. (NYSE:AHR) by 8.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,208 shares of the company’s stock after selling 1,919 shares during the period. The Manufacturers Life Insurance Company’s holdings in American Healthcare REIT were worth $580,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in AHR. Kozak & Associates Inc. purchased a new stake in shares of American Healthcare REIT in the 3rd quarter worth approximately $28,000. Kiely Wealth Advisory Group Inc. purchased a new stake in shares of American Healthcare REIT in the second quarter worth $30,000. Amalgamated Bank purchased a new stake in shares of American Healthcare REIT in the second quarter worth $33,000. Tidemark LLC purchased a new position in shares of American Healthcare REIT in the 3rd quarter worth about $44,000. Finally, Semmax Financial Advisors Inc. purchased a new position in shares of American Healthcare REIT in the 2nd quarter worth about $45,000. Institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Stock Up 0.5 %

AHR opened at $28.47 on Friday. The firm’s 50 day simple moving average is $26.83 and its two-hundred day simple moving average is $21.42. The company has a market capitalization of $4.36 billion and a PE ratio of -59.31. American Healthcare REIT, Inc. has a 1-year low of $12.63 and a 1-year high of $29.99. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.59.

American Healthcare REIT (NYSE:AHR) last released its earnings results on Tuesday, November 12th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.35). American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.87%. The company had revenue of $523.81 million for the quarter, compared to analysts’ expectations of $474.26 million. The company’s revenue was up 12.8% compared to the same quarter last year. As a group, equities analysts forecast that American Healthcare REIT, Inc. will post 1.42 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Royal Bank of Canada raised their price objective on shares of American Healthcare REIT from $28.00 to $30.00 and gave the company an “outperform” rating in a research note on Monday, November 18th. Bank of America lifted their target price on American Healthcare REIT from $27.00 to $31.00 and gave the stock a “buy” rating in a report on Tuesday, September 24th. Morgan Stanley upped their price target on American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a report on Thursday, August 22nd. Colliers Securities raised American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research report on Sunday, October 13th. Finally, KeyCorp raised their price target on shares of American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a report on Monday, September 16th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $25.13.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.